Invivo Therapeutics Holdings Corp.
NVIVDelisted Mar 21, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001292519
Invivo Therapeutics Holdings Corp. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 7, 2024; 14 institutions reported holding it in 13F filings for Q4 2023, worth $68.1K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Invivo Therapeutics Holdings Corp. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 13 | 16 | +3 |
| Shares | 63.0K | 164.2K | +101.2K (+160.5%) |
| Value | $257.0K | $703.0K | +$446.0K (+173.5%) |
New holders (4)
Institutions that held Invivo Therapeutics Holdings Corp. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 27,725 | $119.0K | 0.00% |
| Vanguard Group Inc | 16,946 | $73.0K | 0.00% |
| Two Sigma Investments, LP | 11,521 | $49.0K | 0.00% |
| Two Sigma Advisers, LP | 10,468 | $45.0K | 0.00% |
Sold out (1)
Institutions that held Invivo Therapeutics Holdings Corp. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Bank of America Corp | 1 | $0 |